Ameliorative effects of agomelatine against doxorubicin-induced hepatotoxicity
Abstract Drug-induced hepatotoxicity is a significant impediment to the use of doxorubicin, a commonly employed chemotherapeutic agent with established efficacy in cancer treatment. The present study aimed to determine the potential protective effects of agomelatine against doxorubicin hepatotoxicit...
I tiakina i:
| Ngā kaituhi matua: | , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
BMC
2025-08-01
|
| Rangatū: | BMC Pharmacology and Toxicology |
| Ngā marau: | |
| Urunga tuihono: | https://doi.org/10.1186/s40360-025-00988-y |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|